NEXGEL CEO Adam R. Levy Receives Stock Option Award

What Happened
Adam R. Levy, CEO of NEXGEL, Inc. (NXGL), was granted a derivative award on July 23, 2026: an option to acquire 160,000 shares reported at $0.00 (total reported value $0). This was a grant/award (not a purchase or sale) and represents compensation rather than an immediate cash transaction.

Key Details

• Transaction date: July 23, 2026; filing date: July 29, 2026 (filed 6 days after the transaction, which appears late under Section 16 reporting rules).
• Instrument: Option-style award reported as a derivative; 160,000 shares @ $0.00 (reported value $0).
• Vesting: 40,000 shares vest on December 31, 2026; the remaining 120,000 vest in 36 equal monthly installments of ~3,334 shares beginning January 31, 2027, subject to continued employment (see footnote).
• Change-in-control: Any unvested portion will accelerate and become fully exercisable upon a defined Change in Control per the executive employment agreement.
• Shares owned after the transaction: not specified in the information provided in this filing.

Context
This was an equity compensation grant, not an open-market purchase or sale — such awards are common for executives and are part of pay/retention programs. The award is a derivative (an option to acquire shares) and has a time-based vesting schedule; no exercise or sale occurred at grant. The delayed filing may be noted by investors because Section 16 filings are generally due within two business days of the transaction.